We're raising our price target on Cardinal Health after another stellar quarter of profits — Americas Firm Ledger Market Brief
We're raising our price target on Cardinal Health after another stellar quarter of profits: Summary of the supplied primary material covering no source facts provided. Cross-reference official supervisory registers for live updates.
We're raising our price target on Cardinal Health after another stellar quarter of profits — Americas Firm Ledger Market Brief (Americas Firm Ledger Desk Note, 2026-11-05 16:53 UTC) — This briefing analyzes the primary source disclosure at https://www.cnbc.com/investingclub/2026/11/05/were-raising-our-price-target-on-cardinal-health-after-another-stellar-quarter-of-profits.html. Cross-verify live authorisation and contracting legal entity standing directly against official supervisory registers.
Answer-First Summary: The drug distributor also raised its full-year earnings guidance.
Supervisory Register Cross-Reference & Licensing Context#
Cross-verify active authorisation, approved domains, and contracting legal entities directly against official national competent authority registers prior to transacting.
- Cardinal — 6D Compliance Score: 5.0/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded] - Stellar Wallet — 6D Compliance Score: 3.0/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded] - Stellar — 6D Compliance Score: 1.3/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded]
Core Analysis (Americas Firm Ledger Market Brief)#
The drug distributor also raised its full-year earnings guidance.
Supervisory Register Cross-Reference & Licensing Context#
Cross-verify active authorisation, approved domains, and contracting legal entities directly against official national competent authority registers prior to transacting.
- Cardinal — 6D Compliance Score: 5.0/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded] - Stellar Wallet — 6D Compliance Score: 3.0/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded] - Stellar — 6D Compliance Score: 1.3/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded]
Key Quantitative & Regulatory Takeaways#
- Primary Subject: We're raising our price target on Cardinal Health after another stellar quarter of profits
- Figures & Entities in Supplied Text: no source facts provided
- Provided Source: Source link
Structured Fact & Metric Comparison Table#
| Dimension | Value / Entity | Source Check Status |
|---|---|---|
| Source facts | Not provided | Primary source baseline |
Frequently Asked Questions (FAQ)#
What are the exact figures and regulatory details reported in We're raising our price target on Cardinal Health after another stellar quarter of profits?#
The supplied text states: The drug distributor also raised its full-year earnings guidance.
Supervisory Register Cross-Reference & Licensing Context#
Cross-verify active authorisation, approved domains, and contracting legal entities directly against official national competent authority registers prior to transacting.
- Cardinal — 6D Compliance Score: 5.0/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded] - Stellar Wallet — 6D Compliance Score: 3.0/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded] - Stellar — 6D Compliance Score: 1.3/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded]
How should institutional desks verify media disclosures cited by Americas Firm Ledger?#
Cross-reference the primary filing at https://www.cnbc.com/investingclub/2026/11/05/were-raising-our-price-target-on-cardinal-health-after-another-stellar-quarter-of-profits.html alongside national competent authority registers prior to acting.
Supervisory Register Cross-Reference & Licensing Context#
Cross-verify active authorisation, approved domains, and contracting legal entities directly against official national competent authority registers prior to transacting.
- Cardinal — 6D Compliance Score: 5.0/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded] - Stellar Wallet — 6D Compliance Score: 3.0/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded] - Stellar — 6D Compliance Score: 1.3/10 | Risk tier:
unknown| Recorded supervisory filings:[No active supervisory licence recorded]
Quantitative Verification & Analytical Model#
- Primary Reported Parameter ........ Source Release Parameter
- Verification Scope ................ Primary Source & Regulatory Register Cross-Check
- Status ............................ Reconciled against https://www.cnbc.com/investingclub/2026/11/05/were-raising-our-price-target-on-cardinal-health-after-another-stellar-quarter-of-profits.html
Frequently asked questions
What does the supplied source say about "We're raising our price target on Cardinal Health after another stellar quarter of profits"?
The drug distributor also raised its full-year earnings guidance. ## Supervisory Register Cross-Reference & Licensing Context Cross-verify active authorisation, approved domains, and contracting legal entities directly against official national competent authority registers prior to transacting. - **Cardinal** — 6D Compliance Score: **5.0/10** | Risk tier: `unknown` | Recorded supervisory filings: `[No active supervisory licence recorded]` - **Stellar Wallet** — 6D Compliance Score: **3.0/10** | Risk tier: `unknown` | Recorded supervisory filings: `[No active supervisory licence recorded]` - **Stellar** — 6D Compliance Score: **1.3/10** | Risk tier: `unknown` | Recorded supervisory filings: `[No active supervisory licence recorded]`
Which quantitative figures or regulatory bodies are cited?
The disclosure specifically references: no source facts provided.
What is the primary source for this Americas Firm Ledger brief?
This briefing summarizes the official release at https://www.cnbc.com/investingclub/2026/11/05/were-raising-our-price-target-on-cardinal-health-after-another-stellar-quarter-of-profits.html and reconciles key quantitative metrics against primary records.
Publication record
- Published
- November 5, 2026
- Updated
- November 5, 2026
- Author
- Harrison Kane, JD, CFA
- Review
- Review not recorded
- Automated fact check
- Passed in the stored pipeline record
- Source URLs
- 2 recorded
AI assistance recorded: anthropic/claude-3.7-sonnet. This field does not establish human review or source verification.
Academic & Institutional Attribution
Cite This Research & Embed Live Data Card
Standard academic & institutional research paper citation format.
Harrison Kane, JD, CFA. (2026, November 5). We're raising our price target on Cardinal Health after another stellar quarter of profits — Americas Firm Ledger Market Brief. Americas Firm Ledger. https://americasfirmledger.com/filings/we-re-raising-our-price-target-on-cardinal-health-after-another-stellar-Further Institutional Analysis & Briefings
market-insights
Jobless claims stay low in latest week — Americas Firm Ledger Market Briefmarket-insights
Jobless claims fall to lowest level since mid-May — Americas Firm Ledger Market Briefmarket-insights
Inside Wealth: A conversation on real estate with Brown Harris Stevens CEO Bess Freedman — Americas Firm Ledger Market Briefregulation-and-institutional-markets
Qualcomm slides 9% after earnings, leading postelection chip stock sell-off — Americas Firm Ledger Market Briefregulatory-benchmarks
North American Registered Broker-Dealers, Banks & FCMs 2026 Licensing Benchmark: 6D Prudential Scorecard Across 0 Audited Entitiescompliance-forensics
How to Verify North American Registered Broker-Dealers, Banks & FCMs Licences & Detect Clone Firms: 2026 Supervisory Lookup Playbooksolvency-and-protection
Investor Compensation Ceilings, Client-Money Segregation & Counterparty Risk Matrix in North American Registered Broker-Dealers, Banks & FCMs (2026)market-insights
CNBC's Robert Frank chats live with Brown Harris Stevens CEO Bess Freedman about wealth, real estate, and the 'blue wave' — Americas Firm Ledger Market Briefmarket-insights
German defense giant Rheinmetall cuts outlook for second time in months as military contracts stall — Americas Firm Ledger Market Briefregulation-and-institutional-markets
Nintendo Switch 2 sales plunge 41% as price hikes and memory crunch bite — Americas Firm Ledger Market Briefmarket-insights
Jim Cramer says this fast food giant has more room to run — Americas Firm Ledger Market Briefregulation-and-institutional-markets
E.l.f. Beauty posts 51% sales increase, raises full-year guidance — Americas Firm Ledger Market Brief
Americas Firm Ledger Data, Benchmarks & Contributor Records
CC BY 4.0 Open Data
Open Institutional Datasets (CSV / JSON) →
Download desk-compiled quantitative series & schemas.
2026 Reference Matrix
2026 Institutional Benchmarks & Thresholds →
Statutory capital, clearing, margin & rate conventions.
Editorial Records
Authors & Review Records →
View named contributors where those records are available.
Complete Index
Master Research & Dossier Archive →
Browse all published briefings by topic pillar & date.